AU7142196A - Determination and monitoring of bladder cancer - Google Patents

Determination and monitoring of bladder cancer

Info

Publication number
AU7142196A
AU7142196A AU71421/96A AU7142196A AU7142196A AU 7142196 A AU7142196 A AU 7142196A AU 71421/96 A AU71421/96 A AU 71421/96A AU 7142196 A AU7142196 A AU 7142196A AU 7142196 A AU7142196 A AU 7142196A
Authority
AU
Australia
Prior art keywords
monitoring
determination
bladder cancer
bladder
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71421/96A
Other languages
English (en)
Inventor
Omar El-Ahmady
Roger P. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Ciba Corning Diagnosys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Corning Diagnosys Corp filed Critical Ciba Corning Diagnosys Corp
Publication of AU7142196A publication Critical patent/AU7142196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU71421/96A 1995-10-12 1996-10-11 Determination and monitoring of bladder cancer Abandoned AU7142196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US558595P 1995-10-12 1995-10-12
US005585 1995-10-12
PCT/IB1996/001083 WO1997014037A1 (en) 1995-10-12 1996-10-11 Determination and monitoring of bladder cancer

Publications (1)

Publication Number Publication Date
AU7142196A true AU7142196A (en) 1997-04-30

Family

ID=21716619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71421/96A Abandoned AU7142196A (en) 1995-10-12 1996-10-11 Determination and monitoring of bladder cancer

Country Status (4)

Country Link
EP (1) EP0855027A1 (ja)
JP (1) JP2002515966A (ja)
AU (1) AU7142196A (ja)
WO (1) WO1997014037A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051824A1 (en) * 1997-05-15 1998-11-19 Abbott Laboratories Reagents and methods useful for detecting disease of the urinary tract
WO1998055656A1 (en) * 1997-06-05 1998-12-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
WO1999002734A1 (en) * 1997-07-08 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
JP2010519529A (ja) * 2007-02-23 2010-06-03 プレディクティブ バイオサイエンシーズ コーポレイション 臨床的介入を指向する診断方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers

Also Published As

Publication number Publication date
WO1997014037A1 (en) 1997-04-17
JP2002515966A (ja) 2002-05-28
EP0855027A1 (en) 1998-07-29

Similar Documents

Publication Publication Date Title
AU6763898A (en) Gel sensors and methods of use thereof
AU4198696A (en) Rolling tourniquet
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU5886196A (en) Novel benzopyran compounds and methods for their use
AU1273397A (en) Non-pneumatic tourniquet and method of use
AU1021997A (en) Cd100 antigen and uses therefor
AU5040896A (en) Benzonitriles and benzofluorides
AU3492997A (en) Soi-transistor circuitry employing soi-transistors and method of manufacture thereof
AU4003597A (en) Methods of diagnosing and treating cancer
AU7621496A (en) Microsensor and use of such microsensor
AU5678796A (en) Log converter utilizing offset and method of use thereof
AU2242297A (en) Methods for detection and evaluation of bladder cancer
AU6104896A (en) Therapeutic microdevices and methods of making and using sam e
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3118297A (en) Sok-1 and methods of use
AU6284596A (en) Production of mono-n-alkyl-dinitroalkylanilines and n-alkyl-dinitroaniline derivatives
AU7015396A (en) Cyclin e variants and use thereof
AU3526295A (en) Detection of spread spectrum signals
AU7544396A (en) Triazole derivatives and uses thereof
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU6667196A (en) Determination of chromium
AU7142196A (en) Determination and monitoring of bladder cancer
AU6012696A (en) Prognostic and therapeutic system for cancer
AU1181897A (en) Medical use of proteases
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines